Pediatric generic labeling guidance called off
Executive Summary
FDA no longer plans to issue guidance on labeling for generic drugs when the reference product has protected pediatric labeling. "Since there is little or no action required from the ANDA sponsor on creation of these labeling drafts, a guidance would not be appropriate," agency says. Best Pharmaceuticals for Children Act permits approval of generics without innovator pediatric labeling (1"The Pink Sheet" Jan. 14, 2002, p. 5)...
You may also be interested in...
Barr Expects Metformin Launch By Early February; Pediatric Bill Signed
Barr plans to launch its generic version of Bristol-Myers Squibb's Glucophage (metformin) by early February, CEO Bruce Downey said Jan. 10
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.